Ieq Capital LLC Trims Stock Position in The Cooper Companies, Inc. $COO

Key Points

• Ieq Capital LLC has reduced its stake in The Cooper Companies, Inc. by 26.0%, selling 7,158 shares and now holding a total of 20,339 shares valued at approximately $1.7 million.
• Several institutional investors have increased their positions in Cooper Companies, with Goldman Sachs Group Inc. acquiring an additional 686,751 shares, bringing its total ownership to over 4.7 million shares.
• Analysts have issued mixed ratings on the stock, with price targets varying from $76.00 to $105.00, and an average rating of "Moderate Buy" with a target price of $86.64.

Ieq Capital LLC lowered its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 26.0% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 20,339 shares of the medical device company's stock after selling 7,158 shares during the period. Ieq Capital LLC's holdings in Cooper Companies were worth $1,716,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of COO. Lido Advisors LLC raised its position in shares of Cooper Companies by 14.2% during the 4th quarter. Lido Advisors LLC now owns 3,364 shares of the medical device company's stock worth $309,000 after purchasing an additional 419 shares during the last quarter. AQR Capital Management LLC raised its position in shares of Cooper Companies by 4.2% during the 4th quarter. AQR Capital Management LLC now owns 245,885 shares of the medical device company's stock worth $22,604,000 after purchasing an additional 9,894 shares during the last quarter. Comerica Bank raised its position in shares of Cooper Companies by 7.8% during the 4th quarter. Comerica Bank now owns 77,559 shares of the medical device company's stock worth $7,130,000 after purchasing an additional 5,611 shares during the last quarter. BNP Paribas Financial Markets raised its position in shares of Cooper Companies by 21.5% during the 4th quarter. BNP Paribas Financial Markets now owns 344,500 shares of the medical device company's stock worth $31,670,000 after purchasing an additional 60,979 shares during the last quarter. Finally, BLI Banque de Luxembourg Investments acquired a new position in shares of Cooper Companies during the 4th quarter worth about $11,371,000. Institutional investors and hedge funds own 24.39% of the company's stock.

Analysts Set New Price Targets

COO has been the subject of several research analyst reports. Stifel Nicolaus reduced their price target on shares of Cooper Companies from $90.00 to $85.00 and set a "buy" rating for the company in a research report on Thursday, August 28th. UBS Group raised shares of Cooper Companies to a "buy" rating in a research note on Tuesday, June 17th. Robert W. Baird dropped their price objective on shares of Cooper Companies from $97.00 to $85.00 and set an "outperform" rating for the company in a research note on Thursday, August 28th. Loop Capital set a $100.00 price target on shares of Cooper Companies in a report on Tuesday, June 17th. Finally, Morgan Stanley set a $76.00 price target on shares of Cooper Companies and gave the stock an "equal weight" rating in a report on Thursday, August 28th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $86.64.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, COO Daniel G. Mcbride purchased 3,000 shares of the firm's stock in a transaction on Tuesday, September 2nd. The stock was bought at an average price of $65.04 per share, with a total value of $195,120.00. Following the transaction, the chief operating officer directly owned 63,120 shares of the company's stock, valued at approximately $4,105,324.80. This represents a 4.99% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Gerard H. Warner III acquired 1,450 shares of the firm's stock in a transaction dated Friday, September 5th. The shares were purchased at an average cost of $69.23 per share, with a total value of $100,383.50. Following the completion of the transaction, the chief operating officer owned 18,319 shares in the company, valued at approximately $1,268,224.37. The trade was a 8.60% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders purchased 15,975 shares of company stock worth $1,079,566. 1.98% of the stock is currently owned by corporate insiders.

Cooper Companies Trading Up 0.1%

Shares of NASDAQ:COO traded up $0.09 during mid-day trading on Friday, reaching $68.09. 2,759,386 shares of the company were exchanged, compared to its average volume of 2,951,187. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $112.38. The firm has a market cap of $13.54 billion, a price-to-earnings ratio of 33.54, a P/E/G ratio of 1.72 and a beta of 0.97. The firm's 50-day simple moving average is $71.99 and its 200 day simple moving average is $76.65.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company had revenue of $1.06 billion during the quarter, compared to analysts' expectations of $1.06 billion. During the same quarter last year, the company posted $0.96 EPS. The firm's revenue was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.